Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
13F holders, Q2 2022
Institutional positions in Alvotech as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- +29 vs. Q1 2022
- Shares held
- 6.38M
- +6.38M vs. Q1 2022
- Total value
- $5.40M
- +$5.40M vs. Q1 2022
- New holders
- 29
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALVOW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 7 | $1.16M |
| Q1 2026 | 6 | $1.29M |
| Q4 2025 | 8 | $3.30M |
| Q3 2025 | 10 | $7.74M |
| Q2 2025 | 11 | $9.09M |
| Q1 2025 | 11 | $7.80M |
| Q4 2024 | 10 | $16.3M |
| Q3 2024 | 10 | $15.7M |
| Q2 2024 | 12 | $15.8M |
| Q1 2024 | 12 | $22.4M |
| Q4 2023 | 12 | $14.4M |
| Q3 2023 | 13 | $9.88M |
| Q2 2023 | 14 | $7.22M |
| Q1 2023 | 15 | $13.3M |
| Q4 2022 | 23 | $5.39M |
| Q3 2022 | 26 | $4.54M |
| Q2 2022 | 29 | $5.40M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Alvotech; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 4,666,667 | $3.92M | 0.05% | +4,666,667 | New |
| Highbridge Capital Management LLC | – | $313.0K | 0.01% | – | New |
| Serengeti Asset Management LP | 325,000 | $273.0K | 0.87% | +325,000 | New |
| Linden Advisors LP | 348,640 | $235.0K | 0.00% | +348,640 | New |
| Moore Capital Management, LP | 125,000 | $114.0K | 0.00% | +125,000 | New |
| KCL Capital, L.P. | 83,727 | $70.0K | 0.03% | +83,727 | New |
| Arena Capital Advisors, LLC- CA | 82,967 | $70.0K | 0.02% | +82,967 | New |
| Sculptor Capital LP | 100,000 | $68.0K | 0.00% | +100,000 | New |
| Boussard & Gavaudan Investment Management LLP | 62,500 | $64.0K | 0.01% | +62,500 | New |
| Balyasny Asset Management LLC | 79,314 | $54.0K | 0.00% | +79,314 | New |
| Kim, LLC | 75,000 | $51.0K | 0.00% | +75,000 | New |
| Susquehanna International Group, LLP | 51,944 | $44.0K | 0.00% | +51,944 | New |
| CNH Partners LLC | 31,513 | $26.0K | 0.00% | +31,513 | New |
| HRT Financial LP | 23,672 | $19.0K | 0.00% | +23,672 | New |
| DuPont Capital Management Corp | 18,750 | $16.0K | 0.00% | +18,750 | New |
| Hudson Bay Capital Management LP | 16,250 | $15.0K | 0.00% | +16,250 | New |
| Walleye Capital LLC | 16,375 | $14.0K | 0.00% | +16,375 | New |
| Exos Asset Management LLC | 13,833 | $12.0K | 0.01% | +13,833 | New |
| Walleye Trading LLC | 11,000 | $9.00K | 0.00% | +11,000 | New |
| Castle Creek Arbitrage, LLC | 12,499 | $8.00K | 0.00% | +12,499 | New |
| UBS Group AG | 4,564 | $4.00K | 0.00% | +4,564 | New |
| Barclays PLC | 600 | $1.00K | 0.00% | +600 | New |
| Clear Street LLC | 650 | $1.00K | 0.00% | +650 | New |
| Wolverine Asset Management LLC | 800 | $0 | 0.00% | +800 | New |
| SkyView Investment Advisors, LLC | 1,250 | $0 | 0.00% | +1,250 | New |
| Radcliffe Capital Management, L.P. | 77,670 | – | – | +77,670 | New |
| Verition Fund Management LLC | 42,500 | – | – | +42,500 | New |
| LMR Partners LLP | 60,348 | – | – | +60,348 | New |
| Athos Capital Ltd | 43,287 | – | – | +43,287 | New |